Form D · Pharmaceuticals

Quantum Immunologics, Inc.

Tampa, FL · CIK 0001466289

Offering snapshot reported Sep 24, 2010 · SEC filing

Reported sold
$2.3M
Offering amount: $5M
Investors reported
182
Form D · investor count
Minimum accepted
$12K
Reported outside-investor minimum
First sale
Oct 21, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 24, 2010Initial$2,302,784No comparison182SEC filing
Sep 24, 2010Initial$1,633,201No comparison135SEC filing
Jul 7, 2009Initial$365,000No comparison17SEC filing
Jun 18, 2009Initial$3,703,530No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-148142

Source: Form D, filed Sep 24, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve Allison Director
Bernaldo Bicoy Director
Bernie Bicoy Director
Charles Broes Director, Executive, Promoter
Taina Broes Executive
David J Bryant Director
Josh Coughlin Director, Promoter
Martin Eason Director, Executive
David Harris Director
Cortland Reilly Director
Barry Rooth Executive, Promoter
Raymond Wingard Director
Donald Wright Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1881 West Kennedy Blvd. First Floor
Tampa, FL, 33606